Abstract
Data on mother-to-child transmitted human immunodeficiency virus/hepatitis C virus (HIV/HCV) coinfection are scarce. A prospective observational study with a cohort of 70 HCV-infected children (13 of whom were HIV/HCV-coinfected; mean follow-up: 7.3 years) is presented. In our series, surrogate markers of disease progression (HCV viremia, maximum alanine aminotransferase values, and spontaneous HCV infection clearance) suggest that the evolution of liver disease in HIV/HCV-coinfected pediatric patients is more aggressive than it is in HCV-only infected children.
| Original language | English |
|---|---|
| Pages (from-to) | 801-804 |
| Number of pages | 4 |
| Journal | Pediatric Infectious Disease Journal |
| Volume | 30 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 1 Sept 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antiretrovil therapy
- Hepatitis C Virus
- Coinfection/epidemiology
- Human Immunodeficiency virus
- Mother-to-child transmission
Fingerprint
Dive into the research topics of 'Impact of human immunodeficiency virus coinfection on the progression of mother-to-child transmitted hepatitis C virus infection'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver